Skip to content

A connected system designed to understand and support brain activity over time.

Starting with continuity of neurological care.

Explore the project →

Problem

Neurological disorders such as epilepsy are managed through intermittent consultations, fragmented records, and limited visibility between visits. Most patients are diagnosed at least once, but many fall out of structured follow-up over time.

In contexts where specialists are scarce and data is dispersed across paper, spreadsheets, and legacy tools, clinicians lack a continuous view of patient evolution. Deterioration is often detected late, not because it is invisible, but because it is not connected.

The largest failure is not diagnosis. It is continuity.

Solution

Ampaza is a modular system that combines clinical software, intelligence, and a future connected device to support neurological care safely and progressively.

The software platform is designed to inform and integrate a future device, rather than retrofitting intelligence after hardware deployment.

Approach

Neurological systems are complex, safety-critical, and slow to validate. Ampaza is built around a method that prioritizes risk reduction, interpretability, and long-term viability.

Continuity first

Longitudinal visibility is a prerequisite for any meaningful neurological insight.

Intelligence informs hardware and intervention

Models and decision logic must be explored and validated before acting on the brain.

Modeling as the foundation of closed-loop care

In-silico exploration allows safe evaluation of brain regimes and intervention strategies.

Regulatory discipline throughout

Claims, scope, and usage evolve conservatively, one layer at a time.

Demo

What exists today

A clinical continuity demo focused on longitudinal patient tracking, follow-up visibility, and simple risk signals. Non-therapeutic. No patient data.

What comes next

Progressive integration of modeling, retrospective signal analysis, and research-grade exploration tools.

Access demo →

Early demonstration. Not a medical device.

Scientific & clinical approach

Clinician collaboration

We co-design workflows with clinicians to ensure continuity fits real clinical practice.

Research-driven methodology

Each layer is grounded in evidence, with validation before new capabilities are introduced.

Regulatory discipline and safety

We prioritize safety constraints and regulatory readiness from the earliest software layers.

Founder & vision

The ambition is long-term: to contribute a reliable neuroengineering platform that can scale across contexts, starting where continuity of care is most fragile.
Ampaza is founded by an engineer with an applied research background and direct exposure to hospital environments. Living close to the daily realities of neurological care, he is building Ampaza with a focus on rigor, collaboration with clinicians, and systems designed for real-world conditions.

François DJATE DELBRAH
François DJATE DELBRAH